SCHEMBL28980918

SCHEMBL28980918

O=C1NCC(=O)N2CCN(CC(c3ccccc3)c3ccccc3)CC12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ SIGMAR1 Q99720 1/20 0.37
▸ ACHE P22303 1/20 0.36
▸ KCNA3 P22001 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ OPRL1 P41146 1/20 0.36
▸ MTR Q99707 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ GSK3A P49840 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24152329 0.82 GSK3B (0.50) ALDH1A1SIGMAR1SMN1; SMN2GSK3AGSK3B
SCHEMBL28980928 0.78 DRD2 (0.43) ALDH1A1OPRL1LMNAL3MBTL1GSK3A
SCHEMBL30337586 0.73 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL30337109 0.73 TSHR (0.47) SIGMAR1ACHEOPRM1OPRL1MEN1
SCHEMBL28980935 0.73 KDM4E (0.47) ALDH1A1SMN1; SMN2GSK3AGSK3BMEN1
SCHEMBL30336973 0.73 KMT2A (0.49) SIGMAR1ACHEOPRM1OPRL1MEN1
SCHEMBL30337155 0.73 TACR1 (0.43) ALDH1A1ACHESMN1; SMN2KMT2ATACR1
SCHEMBL30337242 0.72 HTR1A (0.44) OPRM1OPRL1
SCHEMBL24939934 0.72 CYP2D6 (0.56) ALDH1A1LMNATP53SMN1; SMN2L3MBTL1
SCHEMBL24939864 0.71 CHRNA7 (0.49) OPRM1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916206-A Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same 治愈医药社株式会社 2023-04-04 — — CN disclosed
Send feedback